John d. Young

John d. Young (chief executive) discloses dealings in 3 companies, chiefly Pfizer Inc, Johnson Controls International plc and Arvinas, Inc. Between 24 February 2016 and 4 March 2026, the trades on record add up to 71 filings.

The open-market record consists of 10 sales worth €1.4M, with no purchase. Other entries cover 46 share grants and 10 option exercises.

Most recently, on 6 March 2026, the filings show a share grant in Johnson Controls International plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.